Insider · CIK 0001367512

Scale Venture Management II, LLC

CIK 0001367512 Name as filed on the most recent filing

Filed as Scale Venture Management II, LLC (10)

122 transaction lines · from 10 filings · filed 2007-11-16 to 2011-09-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2011-09-21 P, Open-market purchase Zogenix, Inc.ZGNX 2,500,000, acquired Open Form 4 filing 0001209191-11-048745
2011-08-02 P, Open-market purchase Horizon Pharma, Inc.HZNP 2,843,514, acquired Open Form 4 filing 0001209191-11-042516
2010-11-29 P, Open-market purchase Zogenix, Inc.ZGNX 5,000,000, acquired Open Form 4 filing 0001209191-10-057213
2010-11-26 P, Open-market purchase Zogenix, Inc.ZGNX 2,358,580, acquired Open Form 4 filing 0001209191-10-057213
2007-11-21 S, Open-market sale Orexigen Therapeutics, Inc.OREX 1,500, disposed Open Form 4 filing 0001209191-07-065805
2007-11-20 S, Open-market sale Orexigen Therapeutics, Inc.OREX 9,000, disposed Open Form 4 filing 0001209191-07-065504
2007-11-19 S, Open-market sale Orexigen Therapeutics, Inc.OREX 7 lines 33,061, disposed Open Form 4 filing 0001209191-07-065504
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 16 lines 250,682, disposed Open Form 4 filing 0001209191-07-065220
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 60,840, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 39,014, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 31,023, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 28,170, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 25,259, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 25,072, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 23,445, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 21,854, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 20,509, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 18,816, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 18,744, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 15,590, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 14,121, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 14,094, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 12,640, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 12,616, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 11,025, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 10,997, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 9,555, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 9,468, disposed Open Form 4 filing 0001209191-07-065219
2007-11-16 S, Open-market sale Orexigen Therapeutics, Inc.OREX 9,432, disposed Open Form 4 filing 0001209191-07-065219

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Scale Venture Management II, LLC, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001367512

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.